Funding for this research was provided by:
National Natural Science Foundation of China (81801628)
Key Research and Development Projects of Sichuan Science and Technology Department (2020YFS0100)
Received: 17 August 2021
Accepted: 8 December 2021
First Online: 25 March 2022
: This study was approved by the Medicine Ethics Committee of West China Second University Hospital, Sichuan University (NO.2019-18). All patients signed informed consents of this study before SAT analysis. For drug susceptibility analysis, we obtained the data from the Medical Records and Statistics Room hence informed consent waiver for this part of the study is approved by Medicine Ethics Committee of West China Second University Hospital, Sichuan University. We confirm that all methods were performed in accordance with the relevant guidelines and regulations.
: Written informed consent was obtained from the patient and his parents for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare that they have no competing interests.